Ballad Health, an Appalachian company with the nation’s largest state-sanctioned hospital monopoly, may soon be required to improve its quality of care or face the possibility of being broken up.
Risk adjusted net present value: What is the current valuation of Atossa Therapeutics’s Endoxifen? – Pharmaceutical Technology
Share this article The revenue for Endoxifen is expected to reach an annual total of $58 mn by 2035 globally based off GlobalData’s Expiry Model.